Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 - Detailed breakdown
Crime and Safety
| Amount | Description | |
|---|---|---|
| $15,300,000 | Providing additional funds to the FBI for investigative activities associated with Afghan resettlement operations. | |
| $112,500,000 | Appropriating additional funds for security improvements at United States courthouses and Federal court facilities. |
Economy and Commerce
Extension of National Flood Insurance Program
Extends the authority for the National Flood Insurance Program through the duration of the continuing resolution.
Energy and Environment
| Amount | Description | |
|---|---|---|
| $2,500,000,000 | Appropriating funds for the Hermit’s Peak/Calf Canyon Fire Assistance Account. |
Government Operations
Continuing appropriations for fiscal year 2023
Appropriates funds for federal government operations for fiscal year 2023 at the levels provided in the fiscal year 2022 appropriations acts, continuing projects and activities until December 16, 2022.
Oversight for direct financial support to Ukraine
Establishes requirements for funds provided as direct financial support to Ukraine, including third-party monitoring, anti-corruption safeguards, and regular reporting to Congress.
Extension of various federal programs
Extends the authorization for several federal programs, including the FCC's auction authority, the Domestic Trafficking Victims' Fund, and the United States Parole Commission.
New fee adjustment mechanisms for medical devices
Introduces performance and hiring-based adjustments to medical device user fees. Fees may increase if the FDA meets performance goals and decrease if hiring targets are missed.
New capacity planning adjustment for generic drug fees
Implements a new methodology to adjust generic drug fees based on the FDA's resource capacity needs, with adjustments capped at 3% or 4% depending on application volume.
Updates to biosimilar biological product fees
Amends the Federal Food, Drug, and Cosmetic Act to update the fee structure, types, and revenue targets for the biosimilar biological product development and review program for fiscal years 2023-2027.
| Amount | Description | |
|---|---|---|
| $174,000 | Providing a payment to the beneficiary of Jacqueline Walorski-Swihart, a late Representative from Indiana. |
Health
Extension of Medicare, Medicaid, and public health programs
Extends various health programs, including increased payments for low-volume hospitals, the Medicare-dependent hospital program, and maternal and child home visiting programs.
FDA user fee reauthorization act of 2022
Reauthorizes the Food and Drug Administration's authority to collect user fees for prescription drugs, medical devices, generic drugs, and biosimilar biological products through fiscal year 2027.
Medical Device User Fee Amendments of 2022 reauthorization
Reauthorizes the FDA's medical device user fee program for fiscal years 2023 through 2027, allowing the agency to collect fees to expedite the review of device applications.
Conformity assessment program for medical devices
Establishes a program for third-party testing laboratories to be accredited to assess a device's conformity to certain standards, with results generally accepted by the FDA.
Generic Drug User Fee Amendments of 2022 reauthorization
Reauthorizes the FDA's generic drug user fee program for fiscal years 2023 through 2027 to fund the review of generic drug applications.
Biosimilar User Fee Amendments of 2022
Amends provisions related to biosimilar user fees, including updating the definition of the inflation adjustment factor used for fee calculations.
Reauthorization of FDA programs and user fees
Extends authorization for biosimilar user fees and various FDA programs through 2027, setting sunset dates for fee collection and reporting requirements.
| Amount | Description | |
|---|---|---|
| $398,566,000 | Authorizing appropriations for activities related to medical device review. | |
| $582,500,000 | Establishing the total fee revenue amount for human generic drug activities for fiscal year 2023. | |
| $5,273,973 | Reauthorizing the best pharmaceuticals for children program for a portion of fiscal year 2023. | |
| $1,107,534 | Reauthorizing the pediatric device consortia program for a portion of fiscal year 2023. | |
| $1,265,753 | Reauthorizing the critical path public-private partnership for a portion of fiscal year 2023. | |
| $6,328,767 | Reauthorizing orphan drug grants for a portion of fiscal year 2023. |
Infrastructure
| Amount | Description | |
|---|---|---|
| $20,000,000 | Appropriating funds to the Corps of Engineers for water and wastewater infrastructure projects. |
National defense
Restrictions on Department of Defense appropriations
Prohibits funds for the Department of Defense from being used for new production items, increased production rates, or projects that were not funded in fiscal year 2022.
Transfer authority for Operation Allies Welcome
Authorizes the Secretary of Defense to transfer up to $3 billion from unobligated balances to support Operation Allies Welcome or any successor operation for Afghan resettlement.
Accountability report for Ukraine aid
Requires the Secretary of Defense, in coordination with the Secretary of State, to report to Congress on measures being taken to account for United States defense articles designated for Ukraine.
Reporting on security assistance to Ukraine
Requires the Secretary of Defense and Secretary of State to report every 30 days on security assistance provided to Ukraine since the February 24, 2022 Russian invasion.
Increased presidential drawdown authority
Increases the limit for presidential drawdown authority under the Foreign Assistance Act of 1961 from $100,000,000 to $3,700,000,000 for fiscal year 2023.
| Amount | Description | |
|---|---|---|
| $3,000,000,000 | Providing funds for the Ukraine Security Assistance Initiative. | |
| $1,500,000,000 | Replacing defense articles from Department of Defense stocks provided to Ukraine. | |
| $540,000,000 | Expanding production of critical munitions to replace articles provided to Ukraine. | |
| $35,000,000 | Providing funds for Defense Nuclear Nonproliferation to respond to the situation in Ukraine and for related expenses. |
Social services
Continuation of TANF and related programs
Continues activities authorized by part A of title IV of the Social Security Act, including Temporary Assistance for Needy Families (TANF), through the date specified in the continuing resolution.
Compensation for Hermit’s Peak/Calf Canyon Fire victims
Establishes a FEMA-led claims office to compensate victims for losses from the fire. The act also waives state and local matching fund requirements for related federal recovery aid.
Claims process for fire victims
Outlines the process for submitting claims, allowable damages (including property, business, and financial losses), and the timeline for payment for victims of the Hermit's Peak/Calf Canyon Fire.
| Amount | Description | |
|---|---|---|
| $1,000,000,000 | Appropriating additional funds for the Low Income Home Energy Assistance Program (LIHEAP). | |
| $1,775,000,000 | Appropriating additional funds for refugee and entrant assistance activities. | |
| $2,000,000,000 | Appropriating funds for the Community Development Fund for major disasters in 2021 or 2022. |
Veteran affairs
Extension of Veterans Affairs authorities
Extends numerous authorities for the Department of Veterans Affairs related to healthcare, benefits, homeless veterans programs, and specially adapted housing.
Other
| Amount | Description | |
|---|---|---|
| $4,500,000,000 | Providing funds for the Economic Support Fund for assistance to Ukraine. |